Sorrento Therapeutics Inc (NASDAQ:SRNE)

17.29
Delayed Data
As of Jul 06
 +0.61 / +3.66%
Today’s Change
3.10
Today|||52-Week Range
18.28
+71.70%
Year-to-Date

Today’s Trading

Previous close16.68
Today’s open16.58
Day’s range16.28 - 17.39
Volume491,749
Average volume (3 months)575,666
Market cap$604.9M
Dividend yield--
Data as of 3:59pm ET, 07/06/2015

Growth & Valuation

Earnings growth (last year)+10.96%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+731.25%
P/E ratioNM
Price/Sales70.24
Price/Book5.55

Competitors

 Today’s
change
Today’s
% change
OREXOrexigen Therapeutic...+0.01+0.21%
ADXSAdvaxis Inc+0.08+0.43%
TKMRTekmira Pharmaceutic...-0.06-0.52%
OMEDOncoMed Pharmaceutic...+0.14+0.66%
Data as of 3:59pm ET, 07/06/2015

Financials

Next reporting dateSeptember 2, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$3.8M
Annual profit (last year)-$34.7M
Net profit margin-906.07%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Henry H. Ji
Chief Financial Officer, CAO &
VP-Finance
Douglas J. Langston
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers